130 related articles for article (PubMed ID: 37421290)
1. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
Sun X; Wang Z; Chen X; Shen K
Front Cell Dev Biol; 2021; 9():646774. PubMed ID: 33816496
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma.
Mijiti M; Maimaiti A; Chen X; Tuersun M; Dilixiati M; Dilixiati Y; Zhu G; Wu H; Li Y; Turhon M; Abulaiti A; Maimaitiaili N; Yiming N; Kasimu M; Wang Y
Mol Med; 2023 May; 29(1):64. PubMed ID: 37183261
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients.
Hua L; Lei P; Hu Y
Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
6. Identification of LARS as an essential gene for osteosarcoma proliferation through large-Scale CRISPR-Cas9 screening database and experimental verification.
Chen W; Lin Y; Jiang M; Wang Q; Shu Q
J Transl Med; 2022 Aug; 20(1):355. PubMed ID: 35962451
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
[TBL] [Abstract][Full Text] [Related]
8. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
9. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
10. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
[TBL] [Abstract][Full Text] [Related]
11. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
12. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
13. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients.
Chen W; Lin Y; Huang J; Yan Z; Cao H
J Orthop Res; 2022 Oct; 40(10):2372-2381. PubMed ID: 34997639
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
15. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
16. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
[TBL] [Abstract][Full Text] [Related]
17. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic RBPs in Osteosarcoma.
Li B; Fang L; Wang B; Yang Z; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
[TBL] [Abstract][Full Text] [Related]
20. A risk score model for the prediction of osteosarcoma metastasis.
Dong S; Huo H; Mao Y; Li X; Dong L
FEBS Open Bio; 2019 Mar; 9(3):519-526. PubMed ID: 30868060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
